Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 1.940
+0.130 (7.18%)
At close: Jul 28, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 77.6 million as of July 28, 2026. Its market cap has decreased by -9.35% in one year.
Market Cap
77.60M
Enterprise Value
178.87M
Revenue
1.16B
Ranking
n/a
PE Ratio
19.40
Stock Price
1.94
ChartMarket Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 77.60M, a decrease of -56.56%. That is a compound annual growth rate of -5.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 77.60M | -11.82% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rekvina Laboratories | 152.51M |
| Shamrock Industrial Company | 134.17M |
| Emmessar Biotech & Nutrition | 122.15M |
| Ortin Global | 116.77M |
| Beryl Drugs | 107.93M |
| Unjha Formulations | 106.68M |
| Ganga Pharmaceuticals | 70.94M |
| Brawn Biotech | 70.18M |